年轻女性(45至49岁)乳腺筛查中晕征在合成2D乳腺摄影中的诊断价值
本研究评估晕征在断层合成与合成2D乳腺摄影中的临床效能,并识别其诊断价值可能更大的年龄组。183例结节患者从乳腺筛查项目中被召回,分为45-49岁和50-69岁两组,计算不同年龄组的预测值。结论认为晕征在50岁以下女性中可考虑为良性病变标志物,50岁及以上女性应考虑其他乳腺影像技术联合或不联合组织学检查以排除恶性。
要点
- 45-49岁组阳性晕征占76.7%,其中34.8%考虑活检且组织学均为良性。
- 50-69岁组阳性晕征占52%,其中25.5%考虑活检,30.8%为恶性。
- 晕征在50岁以下女性中可考虑为良性病变标志物。
核心结论
- 晕征在50岁以下女性中可考虑为良性病变标志物;50岁及以上女性应考虑其他乳腺影像技术联合或不联合组织学检查以排除恶性。
研究设计与样本
- 从乳腺筛查项目(采用断层合成与合成2D乳腺摄影)中召回183例结节患者,分为45-49岁组和50-69岁组,根据晕征有无计算不同年龄组的预测值。
关键影像表现/征象
- 45-49岁组召回86个结节性病变,66个(76.7%)晕征阳性,20个(23.3%)晕征阴性。
- 50-69岁组召回97例患者的98个结节性病变,51个(52%)晕征阳性,47个(48%)晕征阴性。
诊断标准与关键数值
- 45-49岁组晕征阳性病变中23个(34.8%)考虑活检,组织学特征为良性。
- 50-69岁组晕征阳性病变中13个(25.5%)考虑活检,其中4个(30.8%)为恶性,9个(69.2%)为良性。
临床应用与阅片要点
- 作者认为晕征在50岁以下女性中可考虑为良性病变标志物。
- 作者认为50岁及以上女性应考虑其他乳腺影像技术联合或不联合组织学检查以排除恶性。
- 作者指出阳性晕征作为良性病变标志物的趋势可能改善断层合成与合成2D乳腺摄影筛查项目的召回率和阳性预测值,尤其在年轻女性中。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE:: To assess the clinical performance of the halo sign in tomosynthesis and synthesized 2D mammography, and to identify age groups where its diagnostic value may be greater.
METHODS:: 183 patients with nodules were recalled from the breast screening programme (with tomosynthesis and 2D synthesized mammograms). The patients were separated into two groups, 45-49 years and 50-69 years, and depending on the presence or not of halo sign. We calculated the predictive values for the different age groups.
RESULTS:: In 45-49 years group, 86 nodular lesions were recalled, 66 (76.7%) with positive halo sign and 20 (23.3%) with negative halo sign. In positive halo sign group, biopsy was considered in 23 (34.8%), with histological features of benignity. In 50-69 years group, 98 nodular lesions from 97 patients were recalled, 51 (52%) with positive halo sign and 47 (48%) with negative halo sign. In positive halo sign group, biopsy was considered in 13 (25.5%); four (30.8%) were malignant and nine (69.2%) were benign.
CONCLUSION:: Halo sign could be considered as a marker of benign lesion in females < 50 years. In females ≥ 50 years, other breast imaging techniques should be considered, with or without histological studies, to rule out malignancy.
ADVANCES IN KNOWLEDGE:: The trend of a positive halo sign to act as a marker of benign lesion could be improve the recall rate and positive predictive values in the breast screening programme with tomosynthesis and synthesized 2D mammography, especially in young females.
引用
- Sánchez-Camacho González-Carrato MP, Romero Castellano C, Aguilar Angulo PM, et al. Diagnostic value of halo sign in young women (aged 45 to 49 years) in a breast screening programme with synthesized 2D mammography. Br J Radiol. 2018. PMID: 30059237. doi:10.1259/bjr.20180444
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。